SCYNEXIS Skyrockets on Teaming Up With GSK for Fungal Treatment

SCYNEXIS Skyrockets on Teaming Up With GSK for Fungal Treatment

Source: 
Tip Ranks
snippet: 

Shares of biotechnology company SCYNEXIS (NASDAQ:SCYX) have skyrocketed today after it announced an exclusive licensing deal with GlaxoSmithKline (NYSE:GSK) for brexafemme.